Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
An Na Seo(Kyungpook National University Hospital), Jong Gwang Kim(Kyungpook National University Hospital)
Cited by 48
Related Papers
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
|The Lancet Oncology|2020|190
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)
|Journal of the Korean Gastric Cancer Association|2025|96